Van Berkom & Associates’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,864,545
Closed -$60.9M 62
2024
Q1
$60.9M Sell
3,864,545
-87,364
-2% -$1.48M 1.73% 38
2023
Q4
$77.7M Buy
3,951,909
+819,749
+26% +$14.2M 2.26% 20
2023
Q3
$63.8M Buy
3,132,160
+1,171,837
+60% +$29.5M 2.08% 31
2023
Q2
$57.3M Sell
1,960,323
-25,394
-1% -$696K 2.08% 31
2023
Q1
$55.8M Buy
1,985,717
+117,755
+6% +$3.02M 2.06% 31
2022
Q4
$34.6M Buy
1,867,962
+703,703
+60% +$12.1M 1.48% 40
2022
Q3
$18.3M Sell
1,164,259
-98,388
-8% -$2.21M 0.87% 44
2022
Q2
$31.9M Buy
1,262,647
+481,575
+62% +$14.4M 1.33% 42
2022
Q1
$28.2M Buy
781,072
+101,522
+15% +$5M 1.01% 44
2021
Q4
$52.1M Buy
+679,550
New +$59.9M 1.54% 38

Other funds holding CRNC

Van Berkom & Associates's CRNC Position: Q2 2024 in Review

Van Berkom & Associates sold out of Cerence (CRNC) in Q2 2024, closing a stake of 3,864,545 shares — an estimated $60.9M sold.

Van Berkom & Associates first reported a position in CRNC in Q4 2021 and held it in 10 quarters. The position peaked at $77.7M in Q4 2023. 186 funds tracked by Wall St. Rank hold CRNC as of Q2 2024.

  • Van Berkom & Associates reported no remaining Cerence position as of Q2 2024 after selling out during the quarter.
  • Van Berkom & Associates sold 3,864,545 Cerence shares in Q2 2024, an estimated $60.9M.
  • Van Berkom & Associates first reported a position in Cerence in Q4 2021 and held it in 10 quarters.
  • Van Berkom & Associates's Cerence position peaked at $77.7M in Q4 2023.
  • 186 funds tracked by Wall St. Rank held Cerence as of Q2 2024.

Based on Van Berkom & Associates's 13F filing for Q2 2024, filed 7 Aug 2024.